Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin Tanaka

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Scientific Reports|October 20, 2018
Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantationShin Tanaka, Seiichiro Sugimoto, Takeshi Kurosaki, et al.
General Thoracic and Cardiovascular Surgery|December 16, 2025
Oxygenated blood perfusion provides no additional benefit beyond flow control in lung ischemia-reperfusion injuryTsuyoshi Ryuko, Kentaroh Miyoshi, Kei Matsubara, et al.
Japanese Journal of Clinical Oncology|May 4, 2024
Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancerKazuma Iwata, Ken Suzawa, Kohei Hashimoto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 25, 2025
Recurrent diffuse panbronchiolitis after lung transplantation: Off-label use of inhaled tobramycin for Pseudomonas aeruginosa control in a transplant recipientShin Tanaka, Tuyoshi Ryuko, Yasuaki Tomioka, et al.
Respiratory Investigation|January 3, 2019
Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survivalShin Tanaka, Kentaroh Miyoshi, Hisao Higo, et al.
Experimental Animals|November 9, 2006
Comparison of rat mandible bone characteristics in F344 substrains, F344/Du and F344/NShin Tanaka, Sachi Kuwahara, Kazutoshi Nishijima, et al.
BMC Pulmonary Medicine|July 3, 2025
Co-occurrence of interstitial lung disease and pulmonary embolism as adverse events of adjuvant osimertinib treatment for EGFR mutant non-small cell lung cancer: a case reportKenta Manabe, Kazuhiko Shien, Shinichi Furukawa, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 17, 2025
[Lung Volume Reduction Surgery in the Bronchoscopic Lung Volume Reduction Era:Reassessment of Indications and Strategies]Shin Tanaka, Yasuaki Tomioka, Haruchika Yamamoto, et al.
Respiratory Investigation|January 19, 2024
Long-term outcomes of lung transplantation requiring renal replacement therapy: A single-center experienceYasuaki Tomioka, Seiichiro Sugimoto, Toshio Shiotani, et al.
Surgery Today|June 3, 2023
Elderly lung transplant recipients show acceptable long-term outcomes for lung transplantation: A propensity score-matched analysisYasuaki Tomioka, Shin Tanaka, Shinji Otani, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Scientific Reports|October 20, 2018
Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantationShin Tanaka, Seiichiro Sugimoto, Takeshi Kurosaki, et al.
General Thoracic and Cardiovascular Surgery|December 16, 2025
Oxygenated blood perfusion provides no additional benefit beyond flow control in lung ischemia-reperfusion injuryTsuyoshi Ryuko, Kentaroh Miyoshi, Kei Matsubara, et al.
Japanese Journal of Clinical Oncology|May 4, 2024
Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancerKazuma Iwata, Ken Suzawa, Kohei Hashimoto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 25, 2025
Recurrent diffuse panbronchiolitis after lung transplantation: Off-label use of inhaled tobramycin for Pseudomonas aeruginosa control in a transplant recipientShin Tanaka, Tuyoshi Ryuko, Yasuaki Tomioka, et al.
Respiratory Investigation|January 3, 2019
Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survivalShin Tanaka, Kentaroh Miyoshi, Hisao Higo, et al.
Experimental Animals|November 9, 2006
Comparison of rat mandible bone characteristics in F344 substrains, F344/Du and F344/NShin Tanaka, Sachi Kuwahara, Kazutoshi Nishijima, et al.
BMC Pulmonary Medicine|July 3, 2025
Co-occurrence of interstitial lung disease and pulmonary embolism as adverse events of adjuvant osimertinib treatment for EGFR mutant non-small cell lung cancer: a case reportKenta Manabe, Kazuhiko Shien, Shinichi Furukawa, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 17, 2025
[Lung Volume Reduction Surgery in the Bronchoscopic Lung Volume Reduction Era:Reassessment of Indications and Strategies]Shin Tanaka, Yasuaki Tomioka, Haruchika Yamamoto, et al.
Respiratory Investigation|January 19, 2024
Long-term outcomes of lung transplantation requiring renal replacement therapy: A single-center experienceYasuaki Tomioka, Seiichiro Sugimoto, Toshio Shiotani, et al.
Surgery Today|June 3, 2023
Elderly lung transplant recipients show acceptable long-term outcomes for lung transplantation: A propensity score-matched analysisYasuaki Tomioka, Shin Tanaka, Shinji Otani, et al.
Pageof 18